SCHEMBL6403298

SCHEMBL6403298

[CH2]C(=O)Oc1cc(OC)cc(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
KMT2A Q03164 4/20 0.42
POLB P06746 2/20 0.42
RXRA P19793 1/20 0.42
CYP1A1 P04798 1/20 0.41
CYP1B1 Q16678 1/20 0.41
GAA P10253 2/20 0.40
PARP1 P09874 2/20 0.40
CYP3A4 P08684 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2003787 0.81 CA1 (0.56) ALDH1A1GAAPARP1NPC1RAB9A
SCHEMBL8060232 0.80 ALDH1A1 (0.58) ALDH1A1KMT2APOLBRXRACYP1A1
SCHEMBL919577 0.78 ALDH1A1 (0.55) ALDH1A1KMT2APOLBCYP3A4SMN1; SMN2
SCHEMBL28393758 0.77 ALDH1A1 (0.48) ALDH1A1KMT2APOLBRXRACYP1A1
SCHEMBL2089244 0.76 ALDH1A1 (0.52) ALDH1A1KMT2APOLBRXRAGAA
1,3,5-Trimethoxybenzene SCHEMBL28834629 0.76 ALDH1A1 (0.79) ALDH1A1KMT2APOLBRXRACYP1A1
SCHEMBL19333548 0.76 ELANE (0.47) ALDH1A1KMT2APOLBRXRAGAA
SCHEMBL9970808 0.74 KMT2A (0.53) ALDH1A1KMT2APOLBRXRAGAA
SCHEMBL16960587 0.74 KMT2A (0.44) ALDH1A1KMT2ACYP3A4NPC1RAB9A
SCHEMBL28103049 0.74 ALDH1A1 (0.44) ALDH1A1KMT2APOLBRXRAPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171195-A1 P2X7 antagonists for treating neuropathic pain ABBOTT LABORATORIES 2005-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171195-A1 P2X7 antagonists for treating neuropathic pain P2RX3, P2RX7, P2RX1 ALDH1A1 1730/4885KMT2A 4090/4885POLB 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.